Letter

CSM warning on atypical psychotics and stroke may be detrimental for dementia

BMJ 2004; 328 doi: http://dx.doi.org/10.1136/bmj.328.7450.1262-b (Published 20 May 2004) Cite this as: BMJ 2004;328:1262
  1. Donald Mowat, consultant in old age psychiatry ([email protected]),
  2. Douglas Fowlie, consultant in old age psychiatry
  1. Royal Cornhill Hospital, Aberdeen AB25 2ZH
  1. Tom MacEwan, consultant in old age psychiatry
  1. Royal Cornhill Hospital, Aberdeen AB25 2ZH

    EDITOR—On 9 March the Committee on Safety of Medicines (CSM) advised avoiding olanzapine and risperidone for patients with dementia, reflecting concern over the excess risk of stroke.1

    Antipsychotic drugs have long been used (off licence) in dementia to treat neuropsychiatric disturbance and are highly effective.2 Atypical antipsychotic drugs have recently …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe